Search Results

Cyclosporine

• Source: Funk & Wagnalls New World Encyclopedia. 2018, 1p.

Record details

Effects of combined intense pulsed light and cyclosporine 0.05% eyedrops in ocular surface matrix metalloproteinase-9 levels in patients with moderate-to-severe MGD.

• Authors : Jeon YY; Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, South Korea.; Bae S

Subjects: Matrix Metalloproteinase 9*/Matrix Metalloproteinase 9*/Matrix Metalloproteinase 9*/metabolism ; Cyclosporine*/Cyclosporine*/Cyclosporine*/administration & dosage ; Ophthalmic Solutions*/Ophthalmic Solutions*/Ophthalmic Solutions*/administration & dosage

• Source: Lasers in medical science [Lasers Med Sci] 2024 Aug 01; Vol. 39 (1), pp. 203. Date of Electronic Publication: 2024 Aug 01.Publisher: Springer Country of Publication: England NLM ID: 8611515 Publication Model: Electronic Cited Medium: Internet ISSN: 1435-604X

Record details

Immunosuppression with cyclosporine versus tacrolimus shows distinctive nephrotoxicity profiles within renal compartments.

• Authors : Demirci H; Institute of Functional Anatomy, Charité, Universitätsmedizin Berlin, Berlin, Germany.; Department of Cell- and Neurobiology, Charité, Universitätsmedizin Berlin, Berlin, Germany.

Subjects: Tacrolimus*/Tacrolimus*/Tacrolimus*/pharmacology ; Cyclosporine*/Cyclosporine*/Cyclosporine*/adverse effects ; Cyclosporine*/Cyclosporine*/Cyclosporine*/toxicity

• Source: Acta physiologica (Oxford, England) [Acta Physiol (Oxf)] 2024 Aug; Vol. 240 (8), pp. e14190. Date of Electronic Publication: 2024 Jun 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262545 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Utility of laboratory and blood pressure monitoring in patients with dermatologic disorders receiving cyclosporine.

• Authors : Cepica TB; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, USA.; Powers CM

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Cyclosporine*/Cyclosporine*/Cyclosporine*/administration & dosage; Humans

• Source: Archives of dermatological research [Arch Dermatol Res] 2024 Jul 05; Vol. 316 (7), pp. 461. Date of Electronic Publication: 2024 Jul 05.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X

Record details

Effect of Cyclosporine A on Th1/Th2 Cytokine Production by Decidual Stromal Cells Mediated by Trophoblast-derived Galectin-9.

• Authors : Mei J; Hainan Provincial Key Laboratory for Human Reproductive Medicine and Genetic Research, Key Laboratory of Reproductive Health Diseases Research and Translation (Hainan Medical University) , Ministry of EducationThe First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou, Hainan, China.; Department of Reproductive Medicine, Hainan Provincial Clinical Research Center for Thalassemia, The First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou, China.

Subjects: Galectins*/Galectins*/Galectins*/metabolism ; Trophoblasts*/Trophoblasts*/Trophoblasts*/metabolism ; Trophoblasts*/Trophoblasts*/Trophoblasts*/drug effects

• Source: Reproductive sciences (Thousand Oaks, Calif.) [Reprod Sci] 2024 Jul; Vol. 31 (7), pp. 1903-1914. Date of Electronic Publication: 2024 Jan 25.Publisher: Springer Country of Publication: United States NLM ID: 101291249 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Cyclosporine-Associated Organizing Pneumonia.

• Authors : Singh H; Department of Internal Medicine, Henry Ford Allegiance Health, Jackson, MI.; Patel P

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/adverse effects ; Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/adverse effects

• Source: American journal of therapeutics [Am J Ther] 2024 Jul-Aug 01; Vol. 31 (4), pp. e450-e453. Date of Electronic Publication: 2024 Apr 02.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9441347 Publication Model: Print-Electronic Cited Medium:

Record details

Impact of Topical 0.05% Cyclosporine A Eye Drops on Post-Femtosecond-Assisted Laser In Situ Keratomileusis Ocular Surface Recovery: A Randomized Clinical Trial.

• Authors : Zhao L; Department of Ophthalmology (L.Z., H.D., B.M., Y.Z., Y.L., Y.C., H.Q.), Peking University Third Hospital, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing, China; Department of Ophthalmology (T.Y.), Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/administration & dosage ; Ophthalmic Solutions*/Ophthalmic Solutions*/Ophthalmic Solutions*/administration & dosage ; Keratomileusis, Laser In Situ*/Keratomileusis, Laser In Situ*/Keratomileusis, Laser In Situ*/methods

• Source: Eye & contact lens [Eye Contact Lens] 2024 Aug 01; Vol. 50 (8), pp. 348-356. Date of Electronic Publication: 2024 Jun 11.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101160941 Publication Model: Print-Electronic Cited Medium:

Record details

Hypothermia, bradycardia, and hypotension during glucocorticoid or cyclosporine A therapy in a boy with Kikuchi-Fujimoto disease.

• Authors : Hiramatsu Y; Department of Pediatrics, KKR Sapporo Medical Center, Sapporo, Hokkaido, Japan.; Department of Pediatrics, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.

Subjects: Bradycardia*/Bradycardia*/Bradycardia*/chemically induced ; Bradycardia*/Bradycardia*/Bradycardia*/diagnosis ; Bradycardia*/Bradycardia*/Bradycardia*/etiology

• Source: Modern rheumatology case reports [Mod Rheumatol Case Rep] 2024 Jul 08; Vol. 8 (2), pp. 352-356.Publisher: Oxford University Press Country of Publication: England NLM ID: 101761026 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Comparison of outcomes of immunosuppressive therapy with rabbit versus horse antithymocyte globulin and cyclosporine a in children with acquired severe aplastic anemia.

• Authors : Yoshimi A; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Noellke P

Subjects: Antilymphocyte Serum*/Antilymphocyte Serum*/Antilymphocyte Serum*/therapeutic use ; Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/drug therapy ; Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use

• Source: American journal of hematology [Am J Hematol] 2024 Jul; Vol. 99 (7), pp. 1403-1406. Date of Electronic Publication: 2024 Apr 15.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Remission of diabetes mellitus induced by prednisolone in combination with cyclosporine toxicity in a cat.

• Authors : Cha S; Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea.; Koo Y

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Cat Diseases*/Cat Diseases*/Cat Diseases*/drug therapy ; Cat Diseases*/Cat Diseases*/Cat Diseases*/chemically induced

• Source: Veterinary medicine and science [Vet Med Sci] 2024 Sep; Vol. 10 (5), pp. e1552.Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101678837 Publication Model: Print Cited Medium: Internet ISSN:

Record details